Market Overview

Benzinga's Top Downgrades

Share:
Benzinga's Top Downgrades
Related FUL
The Week Ahead: Netflix Earnings, Comic-Con, 'IPO Thursday' And More
Benzinga's Top Upgrades, Downgrades For July 12, 2018
H.B. Fuller Announces —…–8 Analyst and Investor Day (GuruFocus)
Related BOOT
A Peek Into The Markets: US Stock Futures Signal Higher Start On Wall Street
5 Stocks To Watch For July 5, 2018

 

  • JP Morgan downgraded HB Fuller Co (NYSE: FUL) from Overweight to Neutral. H.B. Fuller shares rose 0.46 percent to close at $48.50 on Tuesday.
  • Analysts at Baird downgraded Boot Barn Holdings Inc (NYSE: BOOT) from Outperform to Neutral. Boot Barn shares fell 2.21 percent to $15.96 in pre-market trading.
  • Berenberg downgraded Freeport-McMoRan Inc (NYSE: FCX) from Hold to Sell. Freeport-McMoRan shares rose 3.01 percent to $15.42 in pre-market trading.
  • Jefferies downgraded W. R. Grace & Co (NYSE: GRA) from Buy to Hold. The price target for W. R. Grace has been lowered from $80 to $70. W. R. Grace shares gained 0.92 percent to close at $67.01 on Tuesday.
  • Analysts at Bernstein downgraded F5 Networks, Inc. (NASDAQ: FFIV) from Outperform to Market Perform. F5 Networks shares rose 0.14 percent to close at $142.81 on Tuesday.
  • Piper Jaffray downgraded Arrowhead Pharmaceuticals Inc (NASDAQ: ARWR) from Overweight to Neutral. Arrowhead Pharmaceuticals shares fell 59 percent to $1.80 in pre-market trading.
  • Analysts at DA Davidson downgraded Texas Capital Bancshares Inc (NASDAQ: TCBI) from Buy to Neutral. Texas Capital Bancshares shares gained 0.42 percent to close at $71.60 on Tuesday.
  • Chardan Capital downgraded Arrowhead Pharmaceuticals Inc (NASDAQ: ARWR) from Buy to Neutral. The price target for Arrowhead Pharmaceuticals has been lowered from $8 to $2. Arrowhead Pharmaceuticals shares fell 59 percent to $1.80 in pre-market trading.
  • Maxim Group downgraded Mantech International Corp (NASDAQ: MANT) from Buy to Hold. Mantech shares rose 0.74 percent to close at $44.83 on Tuesday.

Latest Ratings for FUL

DateFirmActionFromTo
Jul 2018BerenbergInitiates Coverage OnBuy
Feb 2018JP MorganUpgradesNeutralOverweight
Feb 2018Longbow ResearchUpgradesNeutralBuy

View More Analyst Ratings for FUL
View the Latest Analyst Ratings

Posted-In: Top DowngradesDowngrades Analyst Ratings

 

Related Articles (ARWR + BOOT)

View Comments and Join the Discussion!